Nasdaq bear market: 4 screaming bargains that could double your money by 2026

Despite a healthy recovery in October, the stock market endured a turbulent year.For example, broad-based S&P 500It is considered the best barometer of the health of the US stock market.

But it’s still not as bad as tech heavy NASDAQ Composite (^IXIC)has plunged 38% on a peak-to-trough basis since hitting a record high in November 2021.

Image Source: Getty Images.

But there is a silver lining amidst this turmoil: No matter how badly the stock market has performed in the short term in its history, a bull market rally will always eventually lead to a major index (Nasdaq (even composites!) have recovered their losses. This makes a bear market dip a great opportunity to put money in.

In particular, it’s an ideal time to go buy beaten stocks that offer game-changing innovations. Here are his four screaming bargains in the Nasdaq bear market that could see him double his bankroll by 2026.

Teladoc Health

A quick look Teladoc Healthof (TDOC -2.91%) Looking at this year’s sales performance, you might not believe it was a bargain. The company has two large write-downs of his, possibly related to its very expensive acquisition of applied health signaling company Livongo Health. But these one-time costs haven’t changed Teladoc’s growth trajectory or upended the potential of this disruptor.

Teladoc is not a temporary stock. Despite a significant increase in virtual visits during the COVID-19 pandemic, the company has grown sales by an average of 74% annually in his six years through 2020. administered.

Teladoc Health is a compelling company because it improves lives in every aspect of the treatment chain. This brings an element of convenience for patients, while giving doctors a means to monitor chronically ill patients more closely. Virtual visits are also less expensive than in-person visits and may lead to improved patient outcomes. This should make telemedicine a popular promotion for insurance companies. In other words, telemedicine maintains high growth potential.

Finally, don’t miss Livongo Health. Despite overpaying the company, it should ultimately help Teladoc acquire high-margin chronic disease patients and support cross-selling opportunities.

pubmatic

The second screaming bargain in the Nasdaq bear market that could double your money over the next four years is adtech small caps. pubmatic (PUBM -3.87%)Ad revenue is one of the first to take a hit when the US economy weakens, but relatively small players in this programmatic ad space are making big waves.

PubMatic is a sell-side provider (SSP). In short, it helps publishers sell their digital display space. There has been a lot of consolidation in the SSP space in recent years, leaving businesses with few options.

PubMatic not only carves out its niche, but finds itself at the heart of the fastest growing aspect of advertising. According to the company’s presentation, the digital advertising industry is expected to grow 14% annually through his mid-decade.

However, PubMatic consistently grew sales by 20% to 50% year over year. That’s because nearly three-quarters of his revenue comes from programmatic advertising on mobile and connected TV, one of his fastest growing advertising channels.

But, as we pointed out earlier, what makes PubMatic so special is the decision we made to develop and build our own cloud-based infrastructure. With no need to rely on a third-party provider in its programmatic advertising platform, it should lead to higher operating margins than its peers as revenue grows.

Image Source: Getty Images.

Planet 13 Holdings

A third screaming bargain to help patient investors double their money by 2026 is US marijuana stocks. Planet 13 Holdings (PLNH.F -3.94%)Despite the lack of cannabis reform in the Capitol, there is ample state-level organic growth opportunity for fast-paced companies like Planet 13 to succeed.

What really sets Planet 13 apart from other multi-state operators (MSOs) is its superstore. While most MSOs try to establish a presence in 10 or more legal states, Planet 13 only has three clinics, two of which are really large. The Las Vegas Superstore covers 112,000 square feet and features an event center, cafe and consumer processing center. Meanwhile, the Orange County Superstore in California spans 55,000 square feet.

The point here is that Planet 13 stores are more than just sales. It’s an experience that no other cannabis retailer can replicate. Adding to this nostalgia factor, Planet 13 incorporates technology for convenience and relies on a variety of proprietary brand-name, high-margin cannabis derivatives to bring it closer to continued profitability.

However, Planet 13’s future isn’t entirely tied to its SuperStore model. With a medical cannabis retailer license secured in Florida, the company plans to open about half a dozen neighborhood-style stores, each about 4,750 square feet.

By 2024, Florida’s cannabis industry should rank third among U.S. states in terms of annual sales. These neighborhood stores, coupled with the unique SuperStore model, provide Planet 13 with the blueprint for success.

Nio

The fourth screaming bargain that could double your money by 2026 is a China-based electric vehicle (EV) maker. Nio (Nio -2.27%)Despite glaring supply chain concerns, historically high inflation and China’s zero COVID strategy, there are plenty of reasons for patient investors to be excited about what they see from this company.

First and foremost, there is an undeniable long-term opportunity for global EV growth. Most developed countries want to reduce their carbon footprint, and EVs are the most logical answer to doing so. By 2035, about half of all vehicles sold in China are expected to be EVs.

Despite historical supply chain disruptions, Nio has been uniquely positioned on the production side. From June to September, the company delivered 10,000 EVs each month. The company’s management previously suggested it could hit 50,000 EVs per month in about a year if supply chain constraints eased.

But most importantly, Nio lets its innovation speak for itself. For such a relatively new entrant, the company’s introduction of more than six EVs is impressive, some of which could put it head-to-head with established/legacy automakers. ‘s innovative battery subscription as a service, Nio appears to have a path to continued profitability and sustained double-digit sales growth.